Valproate Teratogenicity — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Sodium valproate
Sodium valproate is the correct answer. Maternal valproate exposure during pregnancy is associated with major congenital malformations in around 11% of babies and neurodevelopmental problems in approximately 30–40% of exposed children. Reported malformations include neural-tube, craniofacial, cardiac, limb and urogenital abnormalities. In UK psychiatric practice, valproate must not be prescribed to a woman or girl able to have children unless the Pregnancy Prevention Programme requirements are met. Lithium carries a smaller absolute teratogenic risk, particularly of cardiac malformations. Carbamazepine is also teratogenic but does not carry the characteristic risk magnitude stated. Lamotrigine generally has a more favourable reproductive safety profile, while quetiapine is not associated with this valproate-specific pattern of fetal harm.
Reference: Medicines and Healthcare products Regulatory Agency. Valproate – reproductive risks, section 'The risks of women taking valproate during pregnancy'. Updated 2025. https://www.gov.uk/guidance/valproate-reproductive-risks